Separately, the US drugmaker said data from a new study showed a combination of two of its antibody treatments helped reduce hospitalization and emergency room visits for COVID-19 patients.
Eli Lilly applies for FDA emergency use of COVID-19 treatment
By REUTERS
05/03/2024 09:20 PM
By REUTERS
05/03/2024 09:16 PM
By REUTERS
05/03/2024 08:47 PM
By REUTERS
05/03/2024 08:31 PM
By REUTERS
05/03/2024 08:04 PM
By REUTERS
05/03/2024 06:34 PM
By REUTERS
05/03/2024 06:11 PM
By REUTERS
05/03/2024 05:17 PM
By REUTERS
05/03/2024 05:15 PM
By REUTERS
05/03/2024 04:46 PM
By REUTERS
05/03/2024 04:17 PM